Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$11.23 - $19.44 $1.28 Million - $2.22 Million
114,105 New
114,105 $1.55 Million
Q3 2022

Nov 14, 2022

BUY
$12.2 - $18.71 $175,118 - $268,563
14,354 Added 14.44%
113,774 $1.99 Million
Q2 2022

Aug 15, 2022

SELL
$12.05 - $22.74 $21,894 - $41,318
-1,817 Reduced 1.79%
99,420 $1.31 Million
Q1 2022

May 11, 2022

SELL
$18.32 - $23.03 $2.19 Million - $2.75 Million
-119,342 Reduced 54.1%
101,237 $2.29 Million
Q4 2021

Feb 11, 2022

BUY
$18.75 - $24.8 $13,725 - $18,153
732 Added 0.33%
220,579 $4.9 Million
Q3 2021

Nov 12, 2021

BUY
$19.65 - $31.89 $2.54 Million - $4.13 Million
129,489 Added 143.31%
219,847 $4.71 Million
Q2 2021

Aug 11, 2021

SELL
$29.4 - $35.96 $400,134 - $489,415
-13,610 Reduced 13.09%
90,358 $2.84 Million
Q1 2021

May 13, 2021

SELL
$28.09 - $34.02 $345,450 - $418,377
-12,298 Reduced 10.58%
103,968 $3.31 Million
Q4 2020

Feb 09, 2021

BUY
$20.44 - $30.88 $345,292 - $521,655
16,893 Added 17.0%
116,266 $3.48 Million
Q3 2020

Nov 12, 2020

BUY
$15.68 - $24.28 $10,097 - $15,636
644 Added 0.65%
99,373 $2.36 Million
Q2 2020

Aug 12, 2020

BUY
$10.56 - $18.46 $397,488 - $694,852
37,641 Added 61.62%
98,729 $1.57 Million
Q1 2020

May 06, 2020

BUY
$8.36 - $22.67 $83,892 - $227,493
10,035 Added 19.66%
61,088 $730,000
Q4 2019

Feb 14, 2020

BUY
$15.73 - $21.81 $96,078 - $133,215
6,108 Added 13.59%
51,053 $1.1 Million
Q3 2019

Nov 07, 2019

SELL
$17.15 - $20.26 $4,459 - $5,267
-260 Reduced 0.58%
44,945 $794,000
Q2 2019

Aug 12, 2019

BUY
$15.13 - $20.34 $228,629 - $307,357
15,111 Added 50.21%
45,205 $919,000
Q1 2019

May 14, 2019

BUY
$17.29 - $22.35 $520,325 - $672,600
30,094 New
30,094 $567,000

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $447M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.